tiprankstipranks
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Financial Statements

Compare
57 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.801; its P/E ratio is ―; bioAffinity Technologies, Inc. is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 2.53M$ 4.80K$ 0.00$ 0.00$ 0.00
Gross Profit$ 791.62K$ 4.34K$ -4.82K$ -22.24K$ -40.28K
Operating Income$ -7.97M$ -4.01M$ -2.21M$ -2.60M$ -3.09M
EBITDA$ -7.63M$ -5.61M$ -2.20M$ -6.86M$ -3.05M
Net Income$ -7.94M$ -8.15M$ -6.33M$ -7.27M$ -3.31M
Balance Sheet
Cash & Short-Term Investments$ 2.82M$ 11.41M$ 1.36M$ 83.11K$ 578.48K
Total Assets$ 8.22M$ 12.18M$ 1.45M$ 145.60K$ 658.81K
Total Debt$ 1.58M$ 251.75K$ 11.36M$ 10.01M$ 4.01M
Net Debt$ -1.24M$ -11.16M$ 10.00M$ 9.92M$ 3.43M
Total Liabilities$ 3.37M$ 1.14M$ 17.24M$ 15.22M$ 4.69M
Stockholders' Equity$ 4.86M$ 11.04M$ -15.79M$ -15.07M$ -4.04M
Cash Flow
Free Cash Flow$ -6.06M$ -4.29M$ -2.05M$ -2.21M$ -2.50M
Operating Cash Flow$ -6.04M$ -4.07M$ -2.05M$ -2.21M$ -2.49M
Investing Cash Flow$ -2.21M$ -219.99K$ 0.00$ -2.89K$ -11.40K
Financing Cash Flow$ -344.98K$ 14.34M$ 3.33M$ 1.72M$ 2.33M
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

bioAffinity Technologies, Inc. Debt to Assets

bioAffinity Technologies, Inc. Cash Flow

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis